Press release
Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Report Examines Leading Companies And Growth Opportunities
Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
Projected Market Size and Growth Trajectory for Bioinformatics in IVD Testing
The bioinformatics market within in-vitro diagnostics testing is anticipated to reach a remarkable $133.49 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.0%. This upward trend is propelled by several factors including a rising demand for precision diagnostics, broader adoption of personalized medicine tools, increasing investments in AI-powered diagnostic platforms, expanded use of cloud-based analytics, and growing regulatory acceptance for digital diagnostic methods. Prominent trends predicted to influence the market include enhanced AI-driven diagnostic interpretation software, an uptick in cloud-enabled bioinformatics platforms for IVD, greater integration of molecular and clinical datasets, growth of companion diagnostics analytics, and a stronger focus on real-time data processing in diagnostics.
The bioinformatics in in-vitro diagnostics (ivd) testing market size has grown strongly in recent years. It will grow from $98.89 billion in 2025 to $105.59 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to growth of molecular diagnostic testing volumes, increasing adoption of next-generation sequencing in diagnostics, expansion of centralized diagnostic laboratories, availability of advanced diagnostic hardware, rising use of data-driven clinical decision support.
Download a free sample of the bioinformatics in in-vitro diagnostics (ivd) testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16629&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Players Driving the Bioinformatics in IVD Testing Industry
The competitive landscape of bioinformatics in IVD testing features several influential companies, such as Illumina Inc, Thermo Fisher Scientific Inc, QIAGEN N.V, Agilent Technologies Inc, PerkinElmer Inc, Roche Holding AG, BGI Genomics Co Ltd, DNAnexus Inc, Seven Bridges Genomics Inc, Dassault Systèmes SE (BIOVIA), Genedata AG, Partek Inc, Data4Cure Inc, Ontoforce NV, Geneious (Biomatters), SoftGenetics LLC, Eagle Genomics Ltd, Wuxi NextCODE Genomics, Bio-Rad Laboratories Inc, and Eurofins Scientific SE.
A notable recent development occurred in September 2024, when QIAGEN N.V., a molecular diagnostics firm based in Germany, partnered with US pharmaceutical giant Eli Lilly and Company to develop the first IVD test for APOE genotyping related to Alzheimer's disease. Utilizing QIAGEN's QIAstat-Dx platform, this collaboration signifies a significant clinical advancement in neurodegenerative disease diagnostics and expands QIAGEN's portfolio of diagnostic partnerships. Eli Lilly is recognized for its specialization in In-Vitro Diagnostics Testing.
View the full bioinformatics in in-vitro diagnostics (ivd) testing market report:
https://www.thebusinessresearchcompany.com/report/bioinformatics-in-in-vitro-diagnostics-ivd-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Key Technological Trends Influencing Bioinformatics in IVD Testing
Innovations such as next-generation sequencing (NGS) technology are at the forefront of enhancing genetic mutation detection, improving diagnostic precision, and supporting personalized treatment strategies in the bioinformatics IVD market. NGS allows for the rapid sequencing of whole genomes or targeted DNA and RNA regions, enabling thorough genetic analysis on a large scale.
For example, in January 2024, QIAGEN Digital Insights-the bioinformatics division of QIAGEN-launched LightSpeed, an ultra-fast secondary analysis software accelerator for NGS integrated within its CLC Genomics Workbench Premium platform. LightSpeed dramatically improves the speed of processing somatic cancer NGS data, converting raw sequencing files into variant call format (VCF) within minutes, while lowering the cost per sample. Supporting high-throughput cancer panels, LightSpeed is adaptable to both cloud and on-premises workflows, enabling teams to analyze multiple tumor genes and biomarkers from a single sample efficiently, thereby facilitating precision oncology decisions.
Segment Breakdown and Market Forecasts in Global Bioinformatics in IVD Testing
The market for bioinformatics in in-vitro diagnostics is categorized across several key segments:
1) By Component: Hardware and Software
2) By Type of Test: Blood Based Tests and Tissue Based Tests
3) By Application: Cardiovascular Diseases, Chronic Diseases, Diabetes, Cancer, and Other Applications
Further subsegments include:
- Hardware options such as analyzers, laboratory equipment, data storage devices, sensors and detectors, as well as workstations and data processing hardware.
- Software offerings encompassing bioinformatics platforms, data management and integration software, analytics and interpretation software, cloud-based solutions, and AI-driven diagnostic software.
This detailed segmentation provides insight into the diverse technologies and applications fueling the growth and innovation within the bioinformatics in IVD testing market.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Report Examines Leading Companies And Growth Opportunities here
News-ID: 4603888 • Views: …
More Releases from The Business Research Company
Healthcare Robotics Market Report Provides Insights Into Market Evolution And Gr …
The healthcare robotics industry is on track for significant expansion as technological advancements and innovative applications continue to transform the sector. With AI integration and growing demand for more precise, efficient healthcare solutions, this market is set to experience robust growth in the coming years. Let's explore the projected market size, key players, notable trends, and the primary segments shaping this evolving industry.
Healthcare Robotics Market Size and Its Future Outlook…
Healthcare Quality Management Market Outlook Signals Expansion To $11.03 Billion …
The healthcare quality management market is gaining significant attention as healthcare providers seek smarter, more efficient ways to enhance patient care and compliance. Driven by technological advancements and shifting industry priorities, this market is set for substantial growth in the coming years. Here's an overview of its expected size, leading companies, emerging trends, and market segmentation.
Projected Growth and Market Size of Healthcare Quality Management
The healthcare quality management market…
Healthcare Payment Processing Market Report 2026 Market Outlook Supported By A F …
The healthcare payment processing sector is set to experience substantial growth as digital transformation reshapes the way payments are handled in the medical industry. With advancements in technology and increasing demand for streamlined financial transactions, this market is positioned to expand rapidly in the coming years. Here's an in-depth look at the market's size projections, leading players, emerging trends, and segmentation.
Projected Expansion of the Healthcare Payment Processing Market Through 2030…
Healthcare Mobility Solutions Market Insights Highlight Segment Expansion And Ma …
The healthcare mobility solutions sector is set to experience remarkable expansion over the next several years, driven by advancements in connected care and digital health technologies. As the demand for smarter, more integrated healthcare tools grows, this market is poised to transform how medical services are delivered and managed globally. Here's an in-depth look into the projected market size, key players, emerging trends, and segmentation within this vibrant industry.
Expected Growth…
More Releases for IVD
Transformative Trends Impacting the Cancer In Vitro Diagnostics (IVD) Market Lan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cancer In Vitro Diagnostics (IVD) Market Size By 2025?
The market size for cancer in vitro diagnostics (IVD) has seen significant growth in the past few years. The market value, which is expected to be $13.36 billion in 2024, is projected to increase to $14.32…
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology.
Every possible effort has been taken while researching and analysing…
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of…
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The IVD research report also provides insights of different regions that are contributing market growth.…
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688
The report provides a…
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.
Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256
The Asia-Pacific IVD market is…
